Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature
- 1Otto-von-Guericke-Universität Magdeburg, Department for Pulmonary and Intensive Care Medicine, Magdeburg, Germany
- 2Institute for Cardiovascular Research, University of Leeds, Leeds, UK
- 3Department of Respiratory Medicine, St James's University Hospital, Leeds LS9 7TF, UK
- Correspondence to:
Dr M Elliott, Department of Respiratory Medicine, St James's University Hospital, Leeds LS9 7TF, UK;
markw.elliott{at}leedsth.nhs.uk
- Accepted 23 January 2002
- Revised 5 December 2001
Abstract
The prevalence, prognosis, clinical presentation, pathophysiology, diagnosis, and treatment of the central sleep apnoea syndrome (CSAS) are reviewed and its relationship with congestive heart failure (CHF) is discussed. Adequately powered trials are needed with survival and health status as end points to establish whether correction of sleep related breathing abnormalities improves the outcome in patients with CHF.








